SpyGlass Pharma, Inc. (SGP) — Financial Flexibility Index
SpyGlass Pharma, Inc. (SGP) has a Financial Flexibility Index of -1.56x as of March 2026. Free cash flow of $-12.87 Million (operating CF $-13.54 Million minus capex $676.00K) represents -2% of total liabilities ($8.27 Million). Check SGP cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SpyGlass Pharma, Inc. Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for SpyGlass Pharma, Inc. across 3 annual periods. See SGP working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for SpyGlass Pharma, Inc. (2023–2025)
Year-by-year free cash flow to debt coverage for SpyGlass Pharma, Inc.. For the full company profile including market capitalisation, see SpyGlass Pharma, Inc. (SGP) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.15x | $-31.91 Million | $-32.70 Million | $214.70 Million | ▲ +37.8% |
| 2024 | -0.24x | $-20.04 Million | $-22.03 Million | $83.79 Million | ▼ -47.0% |
| 2023 | -0.16x | $-12.06 Million | $-12.28 Million | $74.13 Million | — |